MUC1 can interact with adenomatous polyposis coli in breast cancer

Biochemical and Biophysical Research Communications

Volumn 316, Issue 2, 2004, Pages 364-369

  Hattrup, Christine L ^a   Fernandez Rodriguez, Julia ^b   Schroeder, Joyce A ^c   Hansson, Gunnar C ^b   Gendler, Sandra J ^a,d  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c University of Arizona   (United States)

^d MAYO GRADUATE SCHOOL   (United States)

Author keywords

APC; Breast cancer; Mammary gland; MUC1

Indexed keywords

BETA CATENIN; EPIDERMAL GROWTH FACTOR; MUCIN 1;

ADENOMATOUS POLYP; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST ADENOMA; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CANCER LOCALIZATION; COLORECTAL CANCER; DISEASE ASSOCIATION; DOWN REGULATION; IMMUNOPRECIPITATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION;

ADENOMATOUS POLYPOSIS COLI PROTEIN; ANIMALS; BREAST NEOPLASMS; CA-15-3 ANTIGEN; CARCINOMA; CELL LINE, TUMOR; EPIDERMAL GROWTH FACTOR; FEMALE; HUMANS; MAMMARY GLANDS, HUMAN; MAMMARY NEOPLASMS, ANIMAL; MICE; NEOPLASM METASTASIS; PRECIPITIN TESTS;

EID: 1542722230     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.02.072     Document Type: Article

References (24)

1. Gendler S.J. MUC1, The renaissance molecule. J. Mammary Gland Biol. Neoplasia. 6:2001;339-353.
2. Girling A., Bartkova J., Burchell J., Gendler S., Gillett C., Taylor-Papadimitriou J. A core protein epitope of the polymorphic epithelial mucin detected by the monoclonal antibody SM-3 is selectively exposed in a range of primary carcinomas. Int. J. Cancer. 43:1989;1072-1076.
3. Zotter S., Hageman P.C., Lossnitzer A., Mooi W.J., Hilgers J. Tissue and tumor distribution of human polymorphic epithelial mucin. Cancer Rev. 11/12:1988;55-101.
4. Tsukamoto A.S., Grosschedl R., Guzman R.C., Parslow T., Varmus H.E. Expression of the int-1 gene in transgenic mice is associated with mammary gland hyperplasia and adenocarcinomas in male and female mice. Cell. 55:1988;619-625.
5. Guy C.T., Cardiff R.D., Muller W.J. Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease. Mol. Cell. Biol. 12:1992;954-961.
6. Schroeder J.A., Adriance M.C., Thompson M.C., Camenisch T.D., Gendler S.J. MUC1 alters beta-catenin-dependent tumor formation and promotes cellular invasion. Oncogene. 22:2003;1324-1332.
7. Spicer A.P., Rowse G.J., Lidner T.K., Gendler S.J. Delayed mammary tumor progression in Muc-1 null mice. J. Biol. Chem. 270:1995;30093-30101.
8. A. Al Masri, J.A. Schroeder, M.C. Adriance, J.C. Tessier, K.L. Kotlarczyk, M.C. Thompson, S.J. Gendler, submitted.
9. Li Y., Liu D., Chen D., Kharbanda S., Kufe D. Human DF3/MUC1 carcinoma-associated protein functions as an oncogene. Oncogene. 22:2003;6107-6110.
10. Spicer A.P., Duhig T., Chilton B.S., Gendler S.J. Analysis of mammalian MUC1 genes reveals potential functionally important domains. Mamm. Genome. 6:1995;885-888.
11. Li Y., Kuwahara H., Ren J., Wen G., Kufe D. The c-Src tyrosine kinase regulates signaling of the human DF3/MUC1 carcinoma-associated antigen with GSK3 beta and beta-catenin. J. Biol. Chem. 276:2001;6061-6064.
12. Schroeder J.A., Thompson M.C., Gardner M.M., Gendler S.J. Transgenic MUC1 interacts with epidermal growth factor receptor and correlates with mitogen-activated protein kinase activation in the mouse mammary gland. J. Biol. Chem. 276:2001;13057-13064.
13. Li Y., Bharti A., Chen D., Gong J., Kufe D. Interaction of glycogen synthase kinase 3beta with the DF3/MUC1 carcinoma-associated antigen and beta-catenin. Mol. Cell. Biol. 18:1998;7216-7224.
14. Ren J., Li Y., Kufe D. Protein kinase C delta regulates function of the DF3/MUC1 carcinoma antigen in beta-catenin signaling. J. Biol. Chem. 277:2002;17616-17622.
15. Schroeder J.A., Adriance M.C., McConnell E.J., Thompson M.C., Pockaj B., Gendler S.J. ErbB-beta-catenin complexes are associated with human infiltrating ductal breast and murine mammary tumor virus (MMTV)-Wnt-1 and MMTV-c-Neu transgenic carcinomas. J. Biol. Chem. 277:2002;22692-22698.
16. Li Y., Chen W., Ren J., Yu W.H., Li Q., Yoshida K., Kufe D. DF3/MUC1 signaling in multiple myeloma cells is regulated by interleukin-7. Cancer Biol. Ther. 2:2003;187-193.
17. Wen Y., Caffrey T.C., Wheelock M.J., Johnson K.R., Hollingsworth M.A. Nuclear association of the cytoplasmic tail of MUC1 and beta-catenin. J. Biol. Chem. 278:2003;38029-38039.
18. Huang L., Ren J., Chen D., Li Y., Kharbanda S., Kufe D. MUC1 cytoplasmic domain coactivates wnt target gene transcription and confers transformation. Cancer Biol. Ther. 2:2003;702-706.
19. Fearnhead N.S., Britton M.P., Bodmer W.F. The ABC of APC. Hum. Mol. Genet. 10:2001;721-733.
20. van Es J.H., Giles R.H., Clevers H.C. The many faces of the tumor suppressor gene APC. Exp. Cell Res. 264:2001;126-134.
21. Sarrio D., Moreno-Bueno G., Hardisson D., Sanchez-Estevez C., Guo M., Herman J.G., Gamallo C., Esteller M., Palacios J. Epigenetic and genetic alterations of APC and CDH1 genes in lobular breast cancer: relationships with abnormal E-cadherin and catenin expression and microsatellite instability. Int. J. Cancer. 106:2003;208-215.
22. Virmani A.K., Rathi A., Sathyanarayana U.G., Padar A., Huang C.X., Cunnigham H.T., Farinas A.J., Milchgrub S., Euhus D.M., Gilcrease M., Herman J., Minna J.D., Gazdar A.F. Aberrant methylation of the adenomatous polyposis coli (APC) gene promoter 1A in breast and lung carcinomas. Clin. Cancer Res. 7:2001;1998-2004.
23. Li Y., Ren J., Yu W., Li Q., Kuwahara H., Yin L., Carraway III K.L., Kufe D. The epidermal growth factor receptor regulates interaction of the human DF3/MUC1 carcinoma antigen with c-Src and beta-catenin. J. Biol. Chem. 276:2001;35239-35242.
24. Roberts G.T., Davies M.L., Wakeman J.A. Interaction between Ku80 protein and a widely used antibody to adenomatous polyposis coli. Br. J. Cancer. 88:2003;202-205.